Related Experiment Video

Updated: Jun 26, 2025

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
00:06

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

8.9K

What Is the Best Local Therapy for HCC?: It Actually Matters More How They All Work Together

Yuman Fong1, Jonathan Kessler2

  • 1Department of Surgery, City of Hope Cancer Center, Duarte, California.

JAMA Surgery
|May 15, 2024
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.2K
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

413

Related Experiment Videos

Last Updated: Jun 26, 2025

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
00:06

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

8.9K
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.2K
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

413

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K

Articles linked to this work by shared authors, journal, and citation graph.

Extended-Release Immunotherapy-Eluting Embolics.

Cancers·2026

Radiopaque microsphere-hydrogel composite for extended-release intratumoral immunotherapy in a large animal model.

Drug delivery and translational research·2026

Racial/ethnic disparities in hepatocellular carcinoma treatment and survival: an analysis of the California Cancer Registry.

Cancer treatment and research communications·2025

Reduced Floxuridine Dose Limits Hepatobiliary Toxicity Without Negatively Impacting Survival After Resection of Colorectal Cancer Liver Metastases.

Annals of surgical oncology·2025

Augmenting the Future Liver Remnant Prior to Major Hepatectomy: A Review of Options on the Menu.

Annals of surgical oncology·2025

Safety and feasibility of percutaneous pulsed electrical field ablation in multiple organs: A multi-center retrospective study☆.

European journal of radiology·2025

Prophylactic Mesh Placement and Incisional Hernia Incidence in Hepatobiliopancreatic Surgery: A Randomized Clinical Trial.

JAMA surgery·2026

Risk of Relapse and Efficacy of Adjuvant Chemotherapy in Localized Appendiceal Adenocarcinoma.

JAMA surgery·2026

An Exosomal Signature for Preoperative Detection of Occult Liver Metastasis in Pancreatic Cancer.

JAMA surgery·2026

Workload and Perceived Burden From a National Survey of Surgeons.

JAMA surgery·2026

Enhanced Recovery After Surgery in Pediatric Urology Patients Undergoing Complex Lower Urinary Tract Reconstruction.

JAMA surgery·2026

Detecting Incisional Surgical Site Infections on Wound Images Through Deep Learning.

JAMA surgery·2026

Serum hepcidin and erythropoietin in relation to anemia in non-diabetic chronic kidney disease: a cross-sectional study.

Scientific reports·2026

After-Hours Surgery Is Associated With Adverse Perioperative Outcomes Following Hemiarthroplasty for Femoral Neck Fracture.

The Journal of arthroplasty·2026

Age-Stratified Conditioning Regimens for Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Myelodysplastic Syndromes: A Comprehensive Review.

Hematological oncology·2026

Impact of Shexiang Baoxin Pill (MUSKARDIA) on Cardiovascular Outcomes by Baseline Hemoglobin Levels in 2,494 Patients with Chronic Stable Coronary Artery Disease: A Secondary Subgroup Analysis.

Chinese journal of integrative medicine·2026

Occult meningeal arterial bleeding in recurrent and postoperative subdural hemorrhage: implications for surgical decision-making and adjunctive middle meningeal artery embolization.

Neurosurgical review·2026

Relationship Between the Systemic Coagulation-Inflammation Index and Radial Artery Occlusion After Transradial Coronary Angiography.

Cardiology research·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us